FURX

Furiex Pharmaceuticals, Inc.CIK 1484478 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for FURX PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for FURX

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Forest Laboratories, LLC	10% Owner	1	$1.06B	$0	2014-07-02
Patel Sailash	Chief Financial Officer	11	$0	$3.58M	2014-07-02
Kaldor Stephen W	Director	20	$0	$594.1K	2014-07-02
Almenoff June Sherie	President	23	$102.9K	$13.27M	2014-07-02
McIntyre Gail Frances	Senior Vice President-Research	26	$0	$9.22M	2014-07-02
DIXON WENDY L	Director	8	$0	$0	2014-07-02
COVINGTON PAUL S	Senior VP-Clinical Operations	17	$0	$7.70M	2014-07-02
CORR PETER B	Director	22	$0	$311.2K	2014-07-02
DAVIS STEPHEN	Director	3	$0	$0	2014-07-02
ESHELMAN FREDRIC N	Director, 10% Owner	30	$13.79M	$0	2014-07-02
Woodworth Marshall H	Chief Financial Officer	2	$0	$0	2013-06-10
Ruscher Robert P	Director	30	$0	$2.60M	2013-03-13

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Kaldor Stephen W	Director	D To issuer deriv	2014-07-02	2014-07-07	5,012	—	$0	0	SEC↗
Kaldor Stephen W	Director	D To issuer deriv	2014-07-02	2014-07-07	8,825	—	$0	0	SEC↗
Kaldor Stephen W	Director	D To issuer deriv	2014-07-02	2014-07-07	17,500	—	$0	0	SEC↗
Almenoff June Sherie	President	D To issuer deriv	2014-07-02	2014-07-07	21,970	—	$0	0	SEC↗
Almenoff June Sherie	President	D To issuer deriv	2014-07-02	2014-07-07	6,912	—	$0	0	SEC↗
Almenoff June Sherie	President	D To issuer deriv	2014-07-02	2014-07-07	83,000	—	$0	0	SEC↗
Almenoff June Sherie	President	D To issuer deriv	2014-07-02	2014-07-07	27,000	—	$0	0	SEC↗
CORR PETER B	Director	D To issuer deriv	2014-07-02	2014-07-07	5,470	—	$0	0	SEC↗
CORR PETER B	Director	D To issuer deriv	2014-07-02	2014-07-07	8,675	—	$0	0	SEC↗
CORR PETER B	Director	D To issuer deriv	2014-07-02	2014-07-07	17,500	—	$0	0	SEC↗
CORR PETER B	Director	D To issuer deriv	2014-07-02	2014-07-07	8,825	—	$0	0	SEC↗
Patel Sailash	Chief Financial Officer	D To issuer deriv	2014-07-02	2014-07-07	26,360	—	$0	0	SEC↗
Patel Sailash	Chief Financial Officer	D To issuer deriv	2014-07-02	2014-07-07	20,000	—	$0	0	SEC↗
Patel Sailash	Chief Financial Officer	D To issuer deriv	2014-07-02	2014-07-07	29,644	—	$0	0	SEC↗
Patel Sailash	Chief Financial Officer	D To issuer deriv	2014-07-02	2014-07-07	8,294	—	$0	0	SEC↗
DIXON WENDY L	Director	D To issuer deriv	2014-07-02	2014-07-07	8,825	—	$0	0	SEC↗
DIXON WENDY L	Director	D To issuer deriv	2014-07-02	2014-07-07	17,500	—	$0	0	SEC↗
DIXON WENDY L	Director	D To issuer deriv	2014-07-02	2014-07-07	8,675	—	$0	0	SEC↗
DIXON WENDY L	Director	D To issuer deriv	2014-07-02	2014-07-07	17,570	—	$0	0	SEC↗
COVINGTON PAUL S	Senior VP-Clinical Operation	D To issuer deriv	2014-07-02	2014-07-07	26,000	—	$0	0	SEC↗
COVINGTON PAUL S	Senior VP-Clinical Operation	D To issuer deriv	2014-07-02	2014-07-07	37,944	—	$0	0	SEC↗
McIntyre Gail Frances	Senior Vice President-Resear	D To issuer deriv	2014-07-02	2014-07-07	26,219	—	$0	0	SEC↗
McIntyre Gail Frances	Senior Vice President-Resear	D To issuer deriv	2014-07-02	2014-07-07	10,368	—	$0	0	SEC↗
McIntyre Gail Frances	Senior Vice President-Resear	D To issuer deriv	2014-07-02	2014-07-07	22,763	—	$0	0	SEC↗
ESHELMAN FREDRIC N	Director, 10% Owner	D To issuer deriv	2014-07-02	2014-07-07	65,876	—	$0	0	SEC↗
ESHELMAN FREDRIC N	Director, 10% Owner	D To issuer deriv	2014-07-02	2014-07-07	98,813	—	$0	0	SEC↗
DAVIS STEPHEN	Director	D To issuer	2014-07-02	2014-07-07	9,308	—	$0	0	SEC↗
Kaldor Stephen W	Director	D To issuer	2014-07-02	2014-07-07	7,160	—	$0	0	SEC↗
Almenoff June Sherie	President	D To issuer	2014-07-02	2014-07-07	24,600	—	$0	0	SEC↗
CORR PETER B	Director	D To issuer	2014-07-02	2014-07-07	8,447	—	$0	0	SEC↗
Patel Sailash	Chief Financial Officer	D To issuer	2014-07-02	2014-07-07	26,444	—	$0	0	SEC↗
DIXON WENDY L	Director	D To issuer	2014-07-02	2014-07-07	7,160	—	$0	0	SEC↗
COVINGTON PAUL S	Senior VP-Clinical Operation	D To issuer	2014-07-02	2014-07-07	22,523	—	$0	0	SEC↗
McIntyre Gail Frances	Senior Vice President-Resear	D To issuer	2014-07-02	2014-07-07	24,318	—	$0	0	SEC↗
ESHELMAN FREDRIC N	Director, 10% Owner	D To issuer	2014-07-02	2014-07-07	132,689	—	$0	0	SEC↗
ESHELMAN FREDRIC N	Director, 10% Owner	D To issuer	2014-07-02	2014-07-07	2,673,522	—	$0	0	SEC↗
ESHELMAN FREDRIC N	Director, 10% Owner	D To issuer	2014-07-02	2014-07-07	140	—	$0	0	SEC↗
ESHELMAN FREDRIC N	Director, 10% Owner	D To issuer	2014-07-02	2014-07-07	41,666	—	$0	0	SEC↗
Forest Laboratories, LLC	10% Owner	P Buy	2014-07-02	2014-07-07	11,169,066	$95.00	$1.06B	0	SEC↗
COVINGTON PAUL S	Senior VP-Clinical Operation	M Exercise deriv	2014-06-24	2014-06-26	10,368	—	$0	0	SEC↗
Patel Sailash	Chief Financial Officer	M Exercise deriv	2014-06-24	2014-06-26	32,928	—	$0	26,360	SEC↗
COVINGTON PAUL S	Senior VP-Clinical Operation	M Exercise	2014-06-24	2014-06-26	10,368	$17.80	$184.6K	32,891	SEC↗
COVINGTON PAUL S	Senior VP-Clinical Operation	S Sale	2014-06-24	2014-06-26	10,368	$104.12	$1.08M	22,523	SEC↗
Patel Sailash	Chief Financial Officer	S Sale	2014-06-24	2014-06-26	32,928	$104.00	$3.42M	26,444	SEC↗
Patel Sailash	Chief Financial Officer	M Exercise	2014-06-24	2014-06-26	32,928	$9.11	$300.0K	59,372	SEC↗
COVINGTON PAUL S	Senior VP-Clinical Operation	M Exercise deriv	2014-06-18	2014-06-20	45,691	—	$0	0	SEC↗
COVINGTON PAUL S	Senior VP-Clinical Operation	S Sale	2014-06-18	2014-06-20	45,691	$104.11	$4.76M	22,523	SEC↗
COVINGTON PAUL S	Senior VP-Clinical Operation	M Exercise	2014-06-18	2014-06-20	45,691	$9.11	$416.2K	68,214	SEC↗
McIntyre Gail Frances	Senior Vice President-Resear	M Exercise deriv	2014-06-17	2014-06-18	8,008	—	$0	26,219	SEC↗
McIntyre Gail Frances	Senior Vice President-Resear	M Exercise	2014-06-17	2014-06-18	8,008	$13.16	$105.4K	32,326	SEC↗
McIntyre Gail Frances	Senior Vice President-Resear	S Sale	2014-06-17	2014-06-18	8,008	$105.00	$840.8K	24,318	SEC↗
McIntyre Gail Frances	Senior Vice President-Resear	M Exercise deriv	2014-06-16	2014-06-18	32,928	—	$0	22,763	SEC↗
McIntyre Gail Frances	Senior Vice President-Resear	M Exercise deriv	2014-06-16	2014-06-18	3,717	—	$0	34,227	SEC↗
McIntyre Gail Frances	Senior Vice President-Resear	M Exercise deriv	2014-06-16	2014-06-18	26,000	—	$0	0	SEC↗
McIntyre Gail Frances	Senior Vice President-Resear	M Exercise	2014-06-16	2014-06-18	3,717	$13.16	$48.9K	28,035	SEC↗
McIntyre Gail Frances	Senior Vice President-Resear	S Sale	2014-06-16	2014-06-18	3,717	$105.05	$390.5K	24,318	SEC↗
McIntyre Gail Frances	Senior Vice President-Resear	S Sale	2014-06-16	2014-06-18	26,000	$105.01	$2.73M	24,318	SEC↗
McIntyre Gail Frances	Senior Vice President-Resear	M Exercise	2014-06-16	2014-06-18	26,000	$15.00	$390.0K	50,318	SEC↗
McIntyre Gail Frances	Senior Vice President-Resear	S Sale	2014-06-16	2014-06-18	32,928	$105.00	$3.46M	24,318	SEC↗
McIntyre Gail Frances	Senior Vice President-Resear	M Exercise	2014-06-16	2014-06-18	32,928	$9.11	$300.0K	57,246	SEC↗
McIntyre Gail Frances	Senior Vice President-Resear	S Sale	2014-06-16	2014-06-18	3,804	$105.00	$399.4K	24,318	SEC↗
COVINGTON PAUL S	Senior VP-Clinical Operation	S Sale	2014-06-13	2014-06-17	3,228	$104.25	$336.5K	22,523	SEC↗
Patel Sailash	Chief Financial Officer	S Sale	2014-06-10	2014-06-12	1,504	$104.68	$157.4K	26,444	SEC↗
McIntyre Gail Frances	Senior Vice President-Resear	S Sale	2014-06-10	2014-06-12	1,746	$104.58	$182.6K	28,122	SEC↗
COVINGTON PAUL S	Senior VP-Clinical Operation	S Sale	2014-06-10	2014-06-12	2,872	$104.63	$300.5K	25,751	SEC↗
DAVIS STEPHEN	Director	A Award	2014-02-28	2014-03-04	3,580	—	$0	9,308	SEC↗
DIXON WENDY L	Director	A Award	2014-02-28	2014-03-04	3,580	—	$0	7,160	SEC↗
CORR PETER B	Director	A Award	2014-02-28	2014-03-04	3,580	—	$0	8,447	SEC↗
COVINGTON PAUL S	Senior VP-Clinical Operation	A Award	2014-02-28	2014-03-04	13,500	—	$0	28,623	SEC↗
Kaldor Stephen W	Director	A Award	2014-02-28	2014-03-04	3,580	—	$0	7,160	SEC↗
Patel Sailash	Chief Financial Officer	A Award	2014-02-28	2014-03-04	12,000	—	$0	27,948	SEC↗
McIntyre Gail Frances	Senior Vice President-Resear	A Award	2014-02-28	2014-03-04	12,000	—	$0	29,868	SEC↗
Almenoff June Sherie	President	M Exercise deriv	2014-02-04	2014-02-06	27,000	—	$0	104,718	SEC↗
Almenoff June Sherie	President	M Exercise deriv	2014-02-04	2014-02-06	21,718	—	$0	83,000	SEC↗
Almenoff June Sherie	President	M Exercise deriv	2014-02-04	2014-02-06	43,939	—	$0	21,970	SEC↗
Almenoff June Sherie	President	M Exercise deriv	2014-02-04	2014-02-06	3,456	—	$0	6,912	SEC↗
Almenoff June Sherie	President	M Exercise deriv	2014-02-04	2014-02-06	19,000	—	$0	27,000	SEC↗
Almenoff June Sherie	President	S Sale	2014-02-04	2014-02-06	21,718	$118.25	$2.57M	24,600	SEC↗
Almenoff June Sherie	President	M Exercise	2014-02-04	2014-02-06	3,456	$17.80	$61.5K	139,713	SEC↗
Almenoff June Sherie	President	S Sale	2014-02-04	2014-02-06	93,395	$114.60	$10.70M	46,318	SEC↗
Almenoff June Sherie	President	M Exercise	2014-02-04	2014-02-06	19,000	$15.00	$285.0K	92,318	SEC↗
Almenoff June Sherie	President	M Exercise	2014-02-04	2014-02-06	21,718	$9.11	$197.9K	73,318	SEC↗
Almenoff June Sherie	President	M Exercise	2014-02-04	2014-02-06	27,000	$9.11	$246.0K	51,600	SEC↗
Almenoff June Sherie	President	M Exercise	2014-02-04	2014-02-06	43,939	$13.16	$578.2K	136,257	SEC↗
Patel Sailash	Chief Financial Officer	A Award	2013-11-15	2013-11-19	1,000	—	$0	15,948	SEC↗
COVINGTON PAUL S	Senior VP-Clinical Operation	M Exercise deriv	2013-09-10	2013-09-12	30,000	—	$0	45,691	SEC↗
COVINGTON PAUL S	Senior VP-Clinical Operation	M Exercise	2013-09-10	2013-09-12	30,000	$9.11	$273.3K	45,123	SEC↗
COVINGTON PAUL S	Senior VP-Clinical Operation	S Sale	2013-09-10	2013-09-12	30,000	$40.89	$1.23M	15,123	SEC↗
CORR PETER B	Director	M Exercise deriv	2013-08-09	2013-08-13	7,500	—	$0	5,470	SEC↗
CORR PETER B	Director	S Sale	2013-08-09	2013-08-13	7,500	$39.74	$298.1K	3,580	SEC↗
CORR PETER B	Director	M Exercise	2013-08-09	2013-08-13	7,500	$9.11	$68.3K	11,080	SEC↗
McIntyre Gail Frances	Senior Vice President-Resear	M Exercise deriv	2013-07-19	2013-07-23	20,000	—	$0	55,691	SEC↗
McIntyre Gail Frances	Senior Vice President-Resear	F Tax w/h	2013-07-19	2013-07-23	9,419	$40.00	$376.8K	28,449	SEC↗
McIntyre Gail Frances	Senior Vice President-Resear	S Sale	2013-07-19	2013-07-23	10,581	$40.00	$423.2K	17,868	SEC↗
McIntyre Gail Frances	Senior Vice President-Resear	M Exercise	2013-07-19	2013-07-23	20,000	$9.11	$182.2K	37,868	SEC↗
McIntyre Gail Frances	Senior Vice President-Resear	S Sale	2013-07-19	2013-09-18	20,000	$40.00	$800.0K	17,868	SEC↗
CORR PETER B	Director	G Gift	2013-07-01	2013-07-02	15	—	$0	3,580	SEC↗
ESHELMAN FREDRIC N	Director, 10% Owner	A Award	2013-06-30	2013-07-02	7,161	—	$0	2,673,522	SEC↗
CORR PETER B	Director	G Gift	2013-06-28	2013-07-02	2,913	—	$0	3,595	SEC↗
CORR PETER B	Director	S Sale	2013-06-28	2013-07-02	385	$34.03	$13.1K	6,508	SEC↗
CORR PETER B	Director	M Exercise	2013-06-25	2013-09-18	1,000	$9.11	$9.1K	8,180	SEC↗
CORR PETER B	Director	M Exercise deriv	2013-06-25	2013-06-26	1,000	—	$0	12,970	SEC↗
CORR PETER B	Director	F Tax w/h	2013-06-25	2013-06-26	400	$33.30	$13.3K	6,893	SEC↗
CORR PETER B	Director	M Exercise	2013-06-25	2013-06-26	1,000	$9.11	$9.1K	7,293	SEC↗
CORR PETER B	Director	M Exercise	2013-06-24	2013-09-18	3,600	$9.11	$32.8K	7,180	SEC↗
CORR PETER B	Director	M Exercise deriv	2013-06-24	2013-06-26	3,600	—	$0	13,970	SEC↗
CORR PETER B	Director	F Tax w/h	2013-06-24	2013-06-26	887	$33.12	$29.4K	6,293	SEC↗
CORR PETER B	Director	M Exercise	2013-06-24	2013-06-26	3,600	$9.11	$32.8K	7,180	SEC↗
Almenoff June Sherie	President	A Award	2013-06-10	2013-06-12	17,600	—	$0	24,600	SEC↗
COVINGTON PAUL S	Senior VP-Clinical Operation	A Award	2013-06-10	2013-06-12	12,200	—	$0	15,123	SEC↗
McIntyre Gail Frances	Senior Vice President-Resear	A Award	2013-06-10	2013-06-12	11,100	—	$0	17,868	SEC↗
Woodworth Marshall H	Chief Financial Officer	A Award	2013-06-10	2013-06-12	10,200	—	$0	16,411	SEC↗
CORR PETER B	Director	A Award	2013-05-24	2013-05-29	3,580	—	$0	3,580	SEC↗
DIXON WENDY L	Director	A Award	2013-05-24	2013-05-29	3,580	—	$0	3,580	SEC↗
Kaldor Stephen W	Director	A Award	2013-05-24	2013-05-29	3,580	—	$0	3,580	SEC↗
DAVIS STEPHEN	Director	A Award	2013-05-24	2013-05-29	5,728	—	$0	5,728	SEC↗
Ruscher Robert P	Director	M Exercise deriv	2013-03-13	2013-03-14	1,822	—	$0	0	SEC↗
Ruscher Robert P	Director	M Exercise deriv	2013-03-13	2013-03-14	1,792	—	$0	0	SEC↗
Ruscher Robert P	Director	M Exercise deriv	2013-03-13	2013-03-14	3,629	—	$0	0	SEC↗
Kaldor Stephen W	Director	M Exercise deriv	2013-03-13	2013-03-14	1,648	—	$0	5,012	SEC↗
Ruscher Robert P	Director	S Sale	2013-03-13	2013-03-14	7,243	$39.96	$289.4K	0	SEC↗
Ruscher Robert P	Director	M Exercise	2013-03-13	2013-03-14	3,629	$9.11	$33.1K	7,243	SEC↗
Ruscher Robert P	Director	M Exercise	2013-03-13	2013-03-14	1,792	$13.94	$25.0K	3,614	SEC↗
Ruscher Robert P	Director	M Exercise	2013-03-13	2013-03-14	1,822	$13.45	$24.5K	1,822	SEC↗
Kaldor Stephen W	Director	S Sale	2013-03-13	2013-03-14	1,648	$39.96	$65.9K	0	SEC↗
Kaldor Stephen W	Director	M Exercise	2013-03-13	2013-03-14	1,648	$13.94	$23.0K	1,648	SEC↗
Ruscher Robert P	Director	M Exercise deriv	2013-03-12	2013-03-14	1,073	—	$0	1,822	SEC↗
Ruscher Robert P	Director	M Exercise deriv	2013-03-12	2013-03-14	1,054	—	$0	1,792	SEC↗
Ruscher Robert P	Director	M Exercise deriv	2013-03-12	2013-03-14	2,135	—	$0	3,629	SEC↗
Kaldor Stephen W	Director	M Exercise deriv	2013-03-12	2013-03-14	973	—	$0	6,660	SEC↗
Kaldor Stephen W	Director	S Sale	2013-03-12	2013-03-13	973	$40.71	$39.6K	1,648	SEC↗
Ruscher Robert P	Director	S Sale	2013-03-12	2013-03-13	4,262	$40.71	$173.5K	7,243	SEC↗
Ruscher Robert P	Director	S Sale	2013-03-12	2013-03-14	4,262	$40.71	$173.5K	0	SEC↗
Ruscher Robert P	Director	M Exercise	2013-03-12	2013-03-14	2,135	$9.11	$19.4K	4,262	SEC↗
Ruscher Robert P	Director	M Exercise	2013-03-12	2013-03-14	1,054	$13.94	$14.7K	2,127	SEC↗
Ruscher Robert P	Director	M Exercise	2013-03-12	2013-03-14	1,073	$13.45	$14.4K	1,073	SEC↗
Kaldor Stephen W	Director	M Exercise	2013-03-12	2013-03-14	973	$13.94	$13.6K	973	SEC↗
Kaldor Stephen W	Director	S Sale	2013-03-12	2013-03-14	973	$40.71	$39.6K	0	SEC↗
Kaldor Stephen W	Director	M Exercise deriv	2013-03-11	2013-03-13	8,000	—	$0	5,012	SEC↗
Ruscher Robert P	Director	M Exercise deriv	2013-03-11	2013-03-13	17,570	—	$0	0	SEC↗
Ruscher Robert P	Director	M Exercise deriv	2013-03-11	2013-03-13	8,675	—	$0	0	SEC↗
Ruscher Robert P	Director	M Exercise deriv	2013-03-11	2013-03-13	8,825	—	$0	0	SEC↗
Ruscher Robert P	Director	M Exercise deriv	2013-03-11	2013-03-14	5,930	—	$0	2,895	SEC↗
Ruscher Robert P	Director	M Exercise deriv	2013-03-11	2013-03-14	5,829	—	$0	2,846	SEC↗
Ruscher Robert P	Director	M Exercise deriv	2013-03-11	2013-03-14	11,806	—	$0	5,764	SEC↗
Kaldor Stephen W	Director	M Exercise deriv	2013-03-11	2013-03-14	5,379	—	$0	7,633	SEC↗
Kaldor Stephen W	Director	S Sale	2013-03-11	2013-03-13	5,379	$41.74	$224.5K	2,621	SEC↗
Kaldor Stephen W	Director	M Exercise	2013-03-11	2013-03-13	8,000	$13.94	$111.5K	8,000	SEC↗
Ruscher Robert P	Director	S Sale	2013-03-11	2013-03-13	23,565	$41.74	$983.6K	11,505	SEC↗
Ruscher Robert P	Director	M Exercise	2013-03-11	2013-03-13	17,570	$9.11	$160.1K	35,070	SEC↗
Ruscher Robert P	Director	M Exercise	2013-03-11	2013-03-13	8,675	$13.94	$120.9K	17,500	SEC↗
Ruscher Robert P	Director	M Exercise	2013-03-11	2013-03-13	8,825	$13.45	$118.7K	8,825	SEC↗
Ruscher Robert P	Director	M Exercise	2013-03-11	2013-03-14	5,829	$13.94	$81.3K	11,759	SEC↗
Ruscher Robert P	Director	M Exercise	2013-03-11	2013-03-14	11,806	$9.11	$107.6K	23,565	SEC↗
Ruscher Robert P	Director	M Exercise	2013-03-11	2013-03-14	5,930	$13.45	$79.8K	5,930	SEC↗
Ruscher Robert P	Director	S Sale	2013-03-11	2013-03-14	23,565	$41.74	$983.6K	0	SEC↗
Kaldor Stephen W	Director	M Exercise	2013-03-11	2013-03-14	5,379	$13.94	$75.0K	5,379	SEC↗
Kaldor Stephen W	Director	S Sale	2013-03-11	2013-03-14	5,379	$41.74	$224.5K	0	SEC↗
Almenoff June Sherie	President	P Buy	2012-08-15	2012-08-16	950	$18.68	$17.7K	7,000	SEC↗
Almenoff June Sherie	President	P Buy	2012-08-14	2012-08-16	50	$18.55	$928	6,050	SEC↗
ESHELMAN FREDRIC N	Director, 10% Owner	M Exercise deriv	2012-06-21	2012-06-22	65,875	—	$0	65,876	SEC↗
ESHELMAN FREDRIC N	Director, 10% Owner	M Exercise	2012-06-21	2012-06-22	65,875	$9.11	$600.1K	132,689	SEC↗
ESHELMAN FREDRIC N	Director, 10% Owner	P Buy	2012-06-14	2012-06-15	34,133	$19.04	$649.9K	2,666,361	SEC↗
ESHELMAN FREDRIC N	Director, 10% Owner	P Buy	2012-06-13	2012-06-15	44,193	$18.33	$810.1K	2,632,228	SEC↗
ESHELMAN FREDRIC N	Director, 10% Owner	P Buy	2012-06-01	2012-06-04	50,319	$19.72	$992.3K	2,588,035	SEC↗
ESHELMAN FREDRIC N	Director, 10% Owner	P Buy	2012-05-31	2012-06-04	70,075	$20.06	$1.41M	2,537,716	SEC↗
ESHELMAN FREDRIC N	Director, 10% Owner	P Buy	2012-05-30	2012-05-31	96,321	$19.87	$1.91M	2,467,641	SEC↗
ESHELMAN FREDRIC N	Director, 10% Owner	P Buy	2012-05-29	2012-05-31	72,431	$19.96	$1.45M	2,371,320	SEC↗
ESHELMAN FREDRIC N	Director, 10% Owner	P Buy	2012-05-25	2012-05-29	1,454	$18.45	$26.8K	2,298,889	SEC↗
CORR PETER B	Director	A Award deriv	2012-05-24	2012-05-29	17,500	—	$0	17,500	SEC↗
DIXON WENDY L	Director	A Award deriv	2012-05-24	2012-05-29	17,500	—	$0	17,500	SEC↗
Kaldor Stephen W	Director	A Award deriv	2012-05-24	2012-05-29	17,500	—	$0	17,500	SEC↗
Ruscher Robert P	Director	A Award deriv	2012-05-24	2012-05-29	17,500	—	$0	17,500	SEC↗
ESHELMAN FREDRIC N	Director, 10% Owner	P Buy	2012-05-24	2012-05-25	27,000	$17.99	$485.7K	2,297,435	SEC↗
ESHELMAN FREDRIC N	Director, 10% Owner	P Buy	2012-05-23	2012-05-24	20,000	$17.73	$354.6K	2,270,435	SEC↗
ESHELMAN FREDRIC N	Director, 10% Owner	P Buy	2012-05-22	2012-05-24	35,000	$16.93	$592.5K	2,250,435	SEC↗
ESHELMAN FREDRIC N	Director, 10% Owner	P Buy	2012-05-21	2012-05-22	2,400	$16.15	$38.8K	2,215,435	SEC↗
ESHELMAN FREDRIC N	Director, 10% Owner	P Buy	2012-05-18	2012-05-21	25,000	$15.28	$382.0K	2,213,035	SEC↗
Almenoff June Sherie	President	P Buy	2012-05-17	2012-05-18	2,000	$14.80	$29.6K	6,000	SEC↗
ESHELMAN FREDRIC N	Director, 10% Owner	P Buy	2012-03-15	2012-03-19	7,102	$23.91	$169.8K	2,188,035	SEC↗
ESHELMAN FREDRIC N	Director, 10% Owner	P Buy	2012-03-14	2012-03-15	22,713	$23.75	$539.4K	2,180,933	SEC↗
ESHELMAN FREDRIC N	Director, 10% Owner	P Buy	2012-03-13	2012-03-15	22,594	$23.45	$529.8K	2,158,220	SEC↗
ESHELMAN FREDRIC N	Director, 10% Owner	P Buy	2012-03-12	2012-03-12	22,351	$22.69	$507.1K	2,060,626	SEC↗
ESHELMAN FREDRIC N	Director, 10% Owner	P Buy	2012-03-09	2012-03-12	15,237	$22.59	$344.2K	2,038,275	SEC↗
ESHELMAN FREDRIC N	Director, 10% Owner	P Buy	2012-03-08	2012-03-12	14,914	$22.52	$335.9K	2,023,038	SEC↗
ESHELMAN FREDRIC N	Director, 10% Owner	P Buy	2012-03-07	2012-03-15	75,000	$21.75	$1.63M	2,135,626	SEC↗
ESHELMAN FREDRIC N	Director, 10% Owner	P Buy	2012-03-06	2012-03-07	15,237	$20.87	$318.0K	2,008,124	SEC↗
ESHELMAN FREDRIC N	Director, 10% Owner	P Buy	2012-03-05	2012-03-07	15,237	$20.55	$313.1K	1,992,887	SEC↗
Almenoff June Sherie	President	A Award deriv	2012-02-24	2012-04-11	10,368	—	$0	10,368	SEC↗
COVINGTON PAUL S	Senior VP-Clinical Operation	A Award deriv	2012-02-24	2012-04-11	10,368	—	$0	10,368	SEC↗
McIntyre Gail Frances	Senior Vice President-Resear	A Award deriv	2012-02-24	2012-04-11	10,368	—	$0	10,368	SEC↗
Woodworth Marshall H	Chief Financial Officer	A Award deriv	2012-02-24	2012-04-11	8,294	—	$0	8,294	SEC↗
Almenoff June Sherie	President	P Buy	2012-02-24	2012-02-28	3,000	$18.21	$54.6K	4,000	SEC↗